Ambev Q2 2026: Organic EBITDA Up 8.9%, Buyback Hits R$3.2B, Tax Win
ABEV sits 49% above its 52-week low of $2.1.
Summary
Ambev reported Q2 2026 organic EBITDA growth of 8.9%, continued its aggressive buyback program with R$3.2 billion in repurchases, and secured a favorable tax ruling canceling a R$623.6 million contingency.
Key Events · Earnings and Guidance · ABEV
-
Q2 2026 Organic EBITDA Growth of 8.9%
Organic EBITDA rose 8.9% on 6.1% higher net revenue, driven by Brazil Beer volumes and margin expansion. Net income reached R$7.36 billion for H1 2026, up from R$6.60 billion a year earlier.
-
Aggressive Share Buyback Continues
The company repurchased 171.5 million shares for R$2.75 billion through June 2026, and an additional 27 million shares in July for R$430 million, bringing the total program cost to approximately R$3.2 billion.
-
R$623.6 Million Tax Contingency Canceled
A unanimous favorable CARF decision canceled a R$623.6 million tax assessment against subsidiary Arosuco, removing a significant contingent liability.
-
New Interest on Capital Distributions Approved
The Board approved R$0.0449 per share (May 2026) and R$0.0713 per share (July 2026) in interest on capital, totaling approximately R$1.8 billion, payable by year-end.
Analysis · ABEV · Manufacturing
Ambev delivered solid Q2 2026 results with organic EBITDA growth of 8.9% on 6.1% higher net revenue, led by Brazil Beer. The company continued its aggressive share buyback, repurchasing R$2.75 billion in shares through June and another R$430 million in July, signaling confidence in its valuation. A favorable CARF ruling canceled a R$623.6 million tax contingency, removing a long-standing overhang. New interest on capital distributions of R$1.8 billion were approved, returning cash to shareholders. The results reinforce Ambev's operational momentum and capital discipline.
At the time of this filing, ABEV was trading at $3.14 on NYSE in the Manufacturing sector, with a market capitalization of approximately $48.8B. The 52-week trading range was $2.10 to $3.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.